303 related articles for article (PubMed ID: 22311714)
21. Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.
Chen YJ; Yu HH; Yang YH; Lau YL; Lee WI; Chiang BL
J Microbiol Immunol Infect; 2014 Dec; 47(6):550-4. PubMed ID: 22921805
[TBL] [Abstract][Full Text] [Related]
22. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
[TBL] [Abstract][Full Text] [Related]
23. TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.
Gerritsma AM; Sutera D; Cantarini L; Cattalini M; Lachmann HJ; Minden K; Jansson AF; Touitou I; Bustaffa M; Antón J; Insalaco A; Moreno E; Sanchez-Manubens J; Ruperto N; Frenkel J; Gattorno M;
Clin Exp Rheumatol; 2023 Oct; 41(10):1998-2007. PubMed ID: 37470237
[TBL] [Abstract][Full Text] [Related]
24. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
Camprubí D; Mitjavila F; Arostegui JI; Corbella X
Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
[TBL] [Abstract][Full Text] [Related]
26. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.
Imazio M; Bobbio M; Cecchi E; Demarie D; Demichelis B; Pomari F; Moratti M; Gaschino G; Giammaria M; Ghisio A; Belli R; Trinchero R
Circulation; 2005 Sep; 112(13):2012-6. PubMed ID: 16186437
[TBL] [Abstract][Full Text] [Related]
27. Recurrent pericarditis: autoimmune or autoinflammatory?
Maestroni S; Di Corato PR; Cumetti D; Chiara DB; Ghidoni S; Prisacaru L; Cantarini L; Imazio M; Penco S; Pedrotti P; Caforio AL; Doria A; Brucato A
Autoimmun Rev; 2012 Nov; 12(1):60-5. PubMed ID: 22884556
[TBL] [Abstract][Full Text] [Related]
28. [Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin].
Bourguiba R; Savey L; Aouba A; Deshayes S; Fain O; Martin-Silva N; Hentgen V; Desdoits A; Grateau G; Giurgea I; Georgin-Lavialle S
Rev Med Interne; 2021 Jul; 42(7):459-464. PubMed ID: 33131906
[TBL] [Abstract][Full Text] [Related]
29. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
[TBL] [Abstract][Full Text] [Related]
30. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-
Gaggiano C; Vitale A; Obici L; Merlini G; Soriano A; Viapiana O; Cattalini M; Maggio MC; Lopalco G; Montin D; Jaber MA; Dagna L; Manna R; Insalaco A; Piga M; La Torre F; Berlengiero V; Gelardi V; Ciarcia L; Emmi G; Ruscitti P; Caso F; Cimaz R; Hernández-Rodríguez J; Parronchi P; Sicignano LL; Verrecchia E; Iannone F; Sota J; Grosso S; Salvarani C; Frediani B; Giacomelli R; Mencarelli MA; Renieri A; Rigante D; Cantarini L
Mediators Inflamm; 2020; 2020():8562485. PubMed ID: 32831641
[TBL] [Abstract][Full Text] [Related]
32. Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center.
Peet CJ; Rowczenio D; Omoyinmi E; Papadopoulou C; Mapalo BRR; Wood MR; Capon F; Lachmann HJ
J Am Heart Assoc; 2022 Jun; 11(11):e024931. PubMed ID: 35658515
[TBL] [Abstract][Full Text] [Related]
33. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
[TBL] [Abstract][Full Text] [Related]
34. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
Radhakrishna SM; Grimm A; Broderick L
BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
[TBL] [Abstract][Full Text] [Related]
35. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
Khabazi A; Maralani M; Andalib S; Sakhinia E
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
[TBL] [Abstract][Full Text] [Related]
36. New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children.
Gaspari S; Marsili M; Imazio M; Brucato A; Di Blasi Lo Cuccio C; Chiarelli F; Breda L
Clin Exp Rheumatol; 2013; 31(5):788-94. PubMed ID: 23981280
[TBL] [Abstract][Full Text] [Related]
37. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults.
Cantarini L; Iacoponi F; Lucherini OM; Obici L; Brizi MG; Cimaz R; Rigante D; Benucci M; Sebastiani GD; Brucato A; Sabadini L; Simonini G; Giani T; Laghi Pasini F; Baldari CT; Bellisai F; Valentini G; Bombardieri S; Paolazzi G; Galeazzi M
Int J Immunopathol Pharmacol; 2011; 24(3):695-702. PubMed ID: 21978701
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
Front Immunol; 2020; 11():576152. PubMed ID: 33162992
[No Abstract] [Full Text] [Related]
39. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
40. Autoinflammatory diseases and cardiovascular manifestations.
Rigante D; Cantarini L; Imazio M; Lucherini OM; Sacco E; Galeazzi M; Brizi MG; Brucato A
Ann Med; 2011 Aug; 43(5):341-6. PubMed ID: 21284530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
